ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 192 filers reported holding ARCUS BIOSCIENCES INC in Q2 2024. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $64,654,716 | +18.8% | 4,245,221 | +47.2% | 0.62% | +23.2% |
| Q1 2024 | $54,443,444 | +174.8% | 2,883,657 | +178.0% | 0.50% | +133.0% |
| Q4 2023 | $19,812,086 | +6.4% | 1,037,282 | 0.0% | 0.22% | -1.4% |
| Q3 2023 | $18,619,212 | +269.7% | 1,037,282 | +318.3% | 0.22% | +263.3% |
| Q2 2023 | $5,036,880 | -79.7% | 248,000 | -79.4% | 0.06% | -81.9% |
| Q4 2022 | $24,839,782 | +201.1% | 1,201,150 | +359.5% | 0.33% | +147.8% |
| Q1 2022 | $8,250,000 | -88.1% | 261,419 | -84.7% | 0.13% | -86.5% |
| Q4 2021 | $69,059,000 | +16.6% | 1,706,425 | +0.4% | 0.99% | +2.3% |
| Q3 2021 | $59,248,000 | +29.7% | 1,699,113 | +2.1% | 0.97% | +13.5% |
| Q2 2021 | $45,682,000 | +31.4% | 1,663,568 | +34.4% | 0.85% | +10.5% |
| Q1 2021 | $34,755,000 | +2442.4% | 1,237,730 | +1156.4% | 0.77% | +686.7% |
| Q1 2020 | $1,367,000 | – | 98,516 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $30,436,014 | 24.20% |
| Decheng Capital LLC | 869,790 | $16,421,635 | 2.20% |
| Boxer Capital, LLC | 1,602,200 | $30,249,536 | 1.49% |
| DAFNA Capital Management LLC | 231,717 | $4,374,817 | 1.00% |
| SECTORAL ASSET MANAGEMENT INC | 93,635 | $1,767,829 | 0.70% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 957,304 | $18,073,900 | 0.67% |
| Parkman Healthcare Partners LLC | 259,920 | $4,907,290 | 0.60% |
| Woodline Partners LP | 2,883,657 | $54,443,444 | 0.50% |
| Granahan Investment Management | 296,570 | $5,599,242 | 0.20% |
| PDT Partners, LLC | 97,152 | $1,834,230 | 0.17% |